June 19, 2023

Morningside Maryland: Rockville Firm Reports Promising Data on Gene Cell Therapy for HIV Cure

Morningside Maryland

View the full Article on:
Morningside Maryland

Addimmune Summary

Original Post in Morningside Maryland

A Rockville-based biotech firm, American Gene Technologies (AGT), has reported promising data on its gene cell therapy for HIV cure. The treatment, which involves genetically modifying a patient’s immune cells to target and eliminate HIV-infected cells, has shown significant promise in early-stage clinical trials.

According to AGT, the therapy has successfully eliminated HIV-infected cells in several patients who have undergone the treatment. The therapy involves taking a patient’s immune cells and genetically modifying them to produce a protein that targets and destroys HIV-infected cells. The modified cells are then infused back into the patient’s body, where they seek out and eliminate the virus.

The therapy has shown significant promise in early-stage clinical trials, with several patients showing a significant reduction in viral load and increased CD4 T-cell counts. AGT is now planning to move forward with more extensive clinical trials to test the therapy’s safety and efficacy.

AGT CEO Expresses Optimism for the Future of HIV Cure

AGT CEO Jeff Galvin expressed optimism for the future of HIV cure, citing the promising data from the company’s gene cell therapy trials. “We believe that our therapy has the potential to be a game-changer in the fight against HIV,” he said. “We’re excited about our progress so far, and we’re looking forward to continuing our research to bring this therapy to more patients.”

Galvin also noted that the therapy could be used in other diseases beyond HIV. “Our therapy is based on a platform technology that can target a wide range of diseases,” he said. “We believe that this technology has the potential to revolutionize the field of gene therapy and to provide new treatments for patients with various conditions.”

Overall, the promising data from AGT’s gene cell therapy trials is a significant development in the quest for a cure for HIV. The therapy has shown considerable promise in early-stage clinical trials and could provide a new treatment option for patients with HIV. As research continues, there is hope that this therapy, and others like it, could help to bring an end to the HIV epidemic finally.